Skip to main content
Premium Trial:

Request an Annual Quote

Population Diagnostics, Empire Genomics Sign Co-Marketing Pact

NEW YORK (GenomeWeb News) - Population Diagnostics and Empire Genomics have signed a co-marketing agreement with the goal of developing molecular diagnostic tests, Population Diagnostics said today.
 
Under the terms of the “multifaceted” deal, EG of Buffalo, NY, will have access to PDI’s core technology platform for discovering copy number polymorphisms. EG will use PDI’s technology to support its internal and collaborative projects, as well as in service and supply relationships with third parties.
 
Melville, NY-based PDI, meanwhile, will use data from EG's array-based comparative genomics platform to build its own technology platform as well as its DNA biomarker discovery program.
 
The companies have also agreed to co-market and co-promote each other’s products and services.
 
PDI has built a working prototype of its platform, which the company claims has helped identify medically relevant biomarkers for autism.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.